-
Je něco špatně v tomto záznamu ?
Guidelines for Biobanking of Bone Marrow Adipose Tissue and Related Cell Types: Report of the Biobanking Working Group of the International Bone Marrow Adiposity Society
S. Lucas, M. Tencerova, B. von der Weid, TL. Andersen, C. Attané, F. Behler-Janbeck, WP. Cawthorn, KK. Ivaska, O. Naveiras, I. Podgorski, MR. Reagan, BCJ. van der Eerden
Jazyk angličtina Země Švýcarsko
Typ dokumentu směrnice, časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, přehledy
Grantová podpora
R01 CA181189
NCI NIH HHS - United States
R01 CA251394
NCI NIH HHS - United States
MR/M021394/1
Medical Research Council - United Kingdom
U54 GM115516
NIGMS NIH HHS - United States
P20 GM121301
NIGMS NIH HHS - United States
MR/S010505/1
Medical Research Council - United Kingdom
R37 CA245330
NCI NIH HHS - United States
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- adipozita MeSH
- banky biologického materiálu MeSH
- kostní dřeň * MeSH
- lidé MeSH
- tkáňové banky organizace a řízení MeSH
- tuková tkáň * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Research Support, N.I.H., Extramural MeSH
- směrnice MeSH
Over the last two decades, increased interest of scientists to study bone marrow adiposity (BMA) in relation to bone and adipose tissue physiology has expanded the number of publications using different sources of bone marrow adipose tissue (BMAT). However, each source of BMAT has its limitations in the number of downstream analyses for which it can be used. Based on this increased scientific demand, the International Bone Marrow Adiposity Society (BMAS) established a Biobanking Working Group to identify the challenges of biobanking for human BMA-related samples and to develop guidelines to advance establishment of biobanks for BMA research. BMA is a young, growing field with increased interest among many diverse scientific communities. These bring new perspectives and important biological questions on how to improve and build an international community with biobank databases that can be used and shared all over the world. However, to create internationally accessible biobanks, several practical and legislative issues must be addressed to create a general ethical protocol used in all institutes, to allow for exchange of biological material internationally. In this position paper, the BMAS Biobanking Working Group describes similarities and differences of patient information (PIF) and consent forms from different institutes and addresses a possibility to create uniform documents for BMA biobanking purposes. Further, based on discussion among Working Group members, we report an overview of the current isolation protocols for human bone marrow adipocytes (BMAds) and bone marrow stromal cells (BMSCs, formerly mesenchymal), highlighting the specific points crucial for effective isolation. Although we remain far from a unified BMAd isolation protocol and PIF, we have summarized all of these important aspects, which are needed to build a BMA biobank. In conclusion, we believe that harmonizing isolation protocols and PIF globally will help to build international collaborations and improve the quality and interpretation of BMA research outcomes.
Center for Molecular Medicine Maine Medical Center Research Institute Scarborough ME United States
Clinical Cell Biology Department of Pathology Odense University Hospital Odense Denmark
Department of Forensic Medicine Aarhus University Aarhus Denmark
Department of Molecular Medicine University of Southern Denmark Odense Denmark
Department of Orthopedics University Medical Center Hamburg Eppendorf Hamburg Germany
Equipe labellisée Ligue contre le cancer Toulouse France
Graduate School for Biomedical Science Tufts University Boston MA United States
Institute of Biomedicine University of Turku Turku Finland
Molecular Physiology of Bone Institute of Physiology of the Czech Academy of Sciences Prague Czechia
School of Life Sciences École Polytechnique Fédérale de Lausanne Lausanne Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012193
- 003
- CZ-PrNML
- 005
- 20220506130834.0
- 007
- ta
- 008
- 220425s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fendo.2021.744527 $2 doi
- 035 __
- $a (PubMed)34646237
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Lucas, Stephanie $u Marrow Adiposity and Bone Lab-MABLab ULR4490, Univ. Littoral Côte d'Opale, Boulogne-sur-Mer, Univ. Lille, CHU Lille, Lille, France
- 245 10
- $a Guidelines for Biobanking of Bone Marrow Adipose Tissue and Related Cell Types: Report of the Biobanking Working Group of the International Bone Marrow Adiposity Society / $c S. Lucas, M. Tencerova, B. von der Weid, TL. Andersen, C. Attané, F. Behler-Janbeck, WP. Cawthorn, KK. Ivaska, O. Naveiras, I. Podgorski, MR. Reagan, BCJ. van der Eerden
- 520 9_
- $a Over the last two decades, increased interest of scientists to study bone marrow adiposity (BMA) in relation to bone and adipose tissue physiology has expanded the number of publications using different sources of bone marrow adipose tissue (BMAT). However, each source of BMAT has its limitations in the number of downstream analyses for which it can be used. Based on this increased scientific demand, the International Bone Marrow Adiposity Society (BMAS) established a Biobanking Working Group to identify the challenges of biobanking for human BMA-related samples and to develop guidelines to advance establishment of biobanks for BMA research. BMA is a young, growing field with increased interest among many diverse scientific communities. These bring new perspectives and important biological questions on how to improve and build an international community with biobank databases that can be used and shared all over the world. However, to create internationally accessible biobanks, several practical and legislative issues must be addressed to create a general ethical protocol used in all institutes, to allow for exchange of biological material internationally. In this position paper, the BMAS Biobanking Working Group describes similarities and differences of patient information (PIF) and consent forms from different institutes and addresses a possibility to create uniform documents for BMA biobanking purposes. Further, based on discussion among Working Group members, we report an overview of the current isolation protocols for human bone marrow adipocytes (BMAds) and bone marrow stromal cells (BMSCs, formerly mesenchymal), highlighting the specific points crucial for effective isolation. Although we remain far from a unified BMAd isolation protocol and PIF, we have summarized all of these important aspects, which are needed to build a BMA biobank. In conclusion, we believe that harmonizing isolation protocols and PIF globally will help to build international collaborations and improve the quality and interpretation of BMA research outcomes.
- 650 12
- $a tuková tkáň $7 D000273
- 650 _2
- $a adipozita $7 D050154
- 650 _2
- $a banky biologického materiálu $7 D018070
- 650 12
- $a kostní dřeň $7 D001853
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tkáňové banky $x organizace a řízení $7 D014015
- 655 _2
- $a směrnice $7 D016431
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Tencerova, Michaela $u Molecular Physiology of Bone, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a von der Weid, Benoit $u School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland $u Swiss Institute of Bioinformatics, Lausanne, Switzerland $u Department of Biomedical Sciences, Faculty of Biology and Medicine, Université de Lausanne, Lausanne, Switzerland
- 700 1_
- $a Andersen, Thomas Levin $u Clinical Cell Biology, Department of Pathology, Odense University Hospital, Odense, Denmark $u Clinical Cell Biology, Pathology Research Unit, Department of Clinical Research, University of Southern Denmark, Odense, Denmark $u Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark $u Department of Forensic Medicine, Aarhus University, Aarhus, Denmark
- 700 1_
- $a Attané, Camille $u Institute of Pharmacology and Structural Biology, Université de Toulouse, CNRS UMR 5089, Toulouse, France $u Equipe labellisée Ligue contre le cancer, Toulouse, France
- 700 1_
- $a Behler-Janbeck, Friederike $u Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany $u Department of Orthopedics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Cawthorn, William P $u British Heart Foundation Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
- 700 1_
- $a Ivaska, Kaisa K $u Institute of Biomedicine, University of Turku, Turku, Finland
- 700 1_
- $a Naveiras, Olaia $u Department of Biomedical Sciences, Faculty of Biology and Medicine, Université de Lausanne, Lausanne, Switzerland $u Hematology Service, Departments of Oncology and Laboratory Medicine, Lausanne University Hospital (CHUV), Université de Lausanne, Lausanne, Switzerland
- 700 1_
- $a Podgorski, Izabela $u Department of Pharmacology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, MI, United States
- 700 1_
- $a Reagan, Michaela R $u Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME, United States $u Graduate School for Biomedical Science, Tufts University, Boston, MA, United States
- 700 1_
- $a van der Eerden, Bram C J $u Laboratory for Calcium and Bone Metabolism, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands
- 773 0_
- $w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 12, č. - (2021), s. 744527
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34646237 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130826 $b ABA008
- 999 __
- $a ok $b bmc $g 1789686 $s 1163394
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 12 $c - $d 744527 $e 20210927 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
- GRA __
- $a R01 CA181189 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA251394 $p NCI NIH HHS $2 United States
- GRA __
- $a MR/M021394/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a U54 GM115516 $p NIGMS NIH HHS $2 United States
- GRA __
- $a P20 GM121301 $p NIGMS NIH HHS $2 United States
- GRA __
- $a MR/S010505/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a R37 CA245330 $p NCI NIH HHS $2 United States
- LZP __
- $a Pubmed-20220425
